Tabas Ira, Bornfeldt Karin E
From the Departments of Medicine (I.T.), Anatomy and Cell Biology (I.T.), and Physiology and Cellular Biophysics (I.T.), Columbia University, New York; and the Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition (K.E.B.) and Department of Pathology (K.E.B.), UW Diabetes Institute, University of Washington School of Medicine, Seattle.
Circ Res. 2016 Feb 19;118(4):653-67. doi: 10.1161/CIRCRESAHA.115.306256.
The remarkable plasticity and plethora of biological functions performed by macrophages have enticed scientists to study these cells in relation to atherosclerosis for >50 years, and major discoveries continue to be made today. It is now understood that macrophages play important roles in all stages of atherosclerosis, from initiation of lesions and lesion expansion, to necrosis leading to rupture and the clinical manifestations of atherosclerosis, to resolution and regression of atherosclerotic lesions. Lesional macrophages are derived primarily from blood monocytes, although recent research has shown that lesional macrophage-like cells can also be derived from smooth muscle cells. Lesional macrophages take on different phenotypes depending on their environment and which intracellular signaling pathways are activated. Rather than a few distinct populations of macrophages, the phenotype of the lesional macrophage is more complex and likely changes during the different phases of atherosclerosis and with the extent of lipid and cholesterol loading, activation by a plethora of receptors, and metabolic state of the cells. These different phenotypes allow the macrophage to engulf lipids, dead cells, and other substances perceived as danger signals; efflux cholesterol to high-density lipoprotein; proliferate and migrate; undergo apoptosis and death; and secrete a large number of inflammatory and proresolving molecules. This review article, part of the Compendium on Atherosclerosis, discusses recent advances in our understanding of lesional macrophage phenotype and function in different stages of atherosclerosis. With the increasing understanding of the roles of lesional macrophages, new research areas and treatment strategies are beginning to emerge.
巨噬细胞具有显著的可塑性和众多生物学功能,这吸引科学家们研究这些细胞与动脉粥样硬化的关系达50多年之久,如今仍不断有重大发现。现在人们认识到,巨噬细胞在动脉粥样硬化的各个阶段都发挥着重要作用,从病变的起始和扩展,到导致斑块破裂和动脉粥样硬化临床表现的坏死,再到动脉粥样硬化病变的消退和逆转。病变部位的巨噬细胞主要来源于血液中的单核细胞,不过最近的研究表明,病变部位类似巨噬细胞的细胞也可来源于平滑肌细胞。病变部位的巨噬细胞根据其所处环境以及激活的细胞内信号通路呈现出不同的表型。病变部位巨噬细胞的表型并非少数几种截然不同的类型,而是更为复杂,并且可能在动脉粥样硬化的不同阶段、随着脂质和胆固醇负荷程度、众多受体的激活以及细胞代谢状态而发生变化。这些不同的表型使巨噬细胞能够吞噬脂质、死亡细胞和其他被视为危险信号的物质;将胆固醇外流至高密度脂蛋白;增殖和迁移;经历凋亡和死亡;并分泌大量炎症和促消退分子。这篇综述文章是《动脉粥样硬化汇编》的一部分,讨论了我们对病变部位巨噬细胞在动脉粥样硬化不同阶段的表型和功能的最新认识进展。随着对病变部位巨噬细胞作用的理解不断加深,新的研究领域和治疗策略开始涌现。